| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.07 (Beat by $0.01) |
| EPS GAAP Actual | $0.07 (Beat by $0.01) |
| Revenue Actual | $0.062808B |
| Revenue Surprise | Beat by $62.808M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.06 |
| EPS GAAP Estimate | $0.06 |
| Revenue Estimate | $0.063225B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0.36 | 16.61 | 0.36 | 0.36 | 1 |
| Dec 2025 | 0.43 | 13.91 | 0.43 | 0.43 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0 | -0.085 | 0.062808B | 1.71% | 0.92M |
| FQ2 2025 (Jun 2025) | 0.13 | 0.06 | 0.065086B | 4.61% | 3.16M |
| FQ1 2025 (Mar 2025) | -0.03 | -0.03 | 0.055652B | -3.7% | 55.65M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0.063474B | -5.32% | 63.47M |
| FQ3 2024 (Sep 2024) | 0.06 | 0.06 | 0.061731B | 3.79% | 61.73M |
| FQ2 2024 (Jun 2024) | 0.08 | 0.08 | 0.062084B | 5.73% | 62.08M |
| FQ1 2024 (Mar 2024) | 0.09 | 0.09 | 0.057712B | 3.12% | 57.71M |
| FQ4 2023 (Dec 2023) | 0.22 | 0.22 | 0.066849B | -0.61% | 66.85M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.06
Consensus Revenue Estimates
0.063225B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.12 | -- | 0.12 | 0.12 | 1 |
| FQ3 2027 (Sep 2027) | 0.09 | -- | 0.09 | 0.09 | 1 |
| FQ2 2027 (Jun 2027) | 0.08 | -- | 0.08 | 0.08 | 1 |
| FQ1 2027 (Mar 2027) | 0.06 | -- | 0.06 | 0.06 | 1 |
| FQ4 2026 (Oct 2026) | 0.15 | -- | 0.14935 | 0.15064 | 0 |
| FQ3 2026 (Jul 2026) | 0.09 | -- | 0.08961211 | 0.0903831 | 0 |
| FQ2 2026 (Jun 2026) | 0.09 | -44.44 | 0.08890602 | 0.09107544 | 0 |
| FQ1 2026 (Mar 2026) | 0.06 | 150 | 0.05927068 | 0.06071696 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.06B | -- | 0.06B | 0.06B | 1 |
| FQ3 2027 (Sep 2027) | 0.06B | -- | 0.06B | 0.06B | 1 |
| FQ2 2027 (Jun 2027) | 0.06B | -- | 0.06B | 0.06B | 1 |
| FQ1 2027 (Mar 2027) | 0.06B | -- | 0.06B | 0.06B | 1 |
| FQ4 2026 (Oct 2026) | 0.07B | -- | 0.07B | 0.07B | 0 |
| FQ3 2026 (Jul 2026) | 0.07B | 5.12 | 0.07B | 0.07B | 0 |
| FQ2 2026 (Jun 2026) | 0.07B | 1.68 | 0.07B | 0.07B | 1 |
| FQ1 2026 (Mar 2026) | 0.06B | 11.98 | 0.06B | 0.06B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.085 | 0 | -0.085 | -INF% |
| FQ2 2025 (Jun 2025) | 0.07 | 0.13 | 0.06 | 46.15% |
| FQ1 2025 (Mar 2025) | -0.03 | -0.03 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 0.06 | 0.06 | 100% | |
| FQ2 2024 (Jun 2024) | 0.08 | 0.08 | 100% | |
| FQ1 2024 (Mar 2024) | 0.09 | 0.09 | 100% | |
| FQ4 2023 (Dec 2023) | 0.22 | 0.22 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.06B | $0.06B | $0.92M | 1.47% |
| FQ2 2025 (Jun 2025) | $0.06B | $0.07B | $3.16M | 4.85% |
| FQ1 2025 (Mar 2025) | $0B | $0.06B | $55.65M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.06B | $63.47M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.06B | $61.73M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.06B | $62.08M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.06B | $57.71M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.07B | $66.85M | 100% |